Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2110

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9A
Chunk 2110
---

     
    Exhibit 10.8 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023
  
    10.7
     
    Securities
    Purchase Agreement dated as of May 24, 2022, by and between Registrant and Cavalry Investment Fund, LP
     
    Exhibit 10.10 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023
  
    10.8
     
    Common
    Stock Purchase Warrant dated as of May 24, 2022, issued by the Registrant to Cavalry Investment Fund, LP
     
    Exhibit 10.11 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023
  
    10.9
     
    Securities
    Purchase Agreement dated as of May 24, 2022, by and between Registrant and Walleye Opportunities Master Fund Ltd
     
    Exhibit 10.13 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023
  
    10.10
     
    Common
    Stock Purchase Warrant dated as of May 24, 2022, issued by the Registrant to Walleye Opportunities Master Fund Ltd
     
    Exhibit 10.14 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023

    10.11
     
    Inter-Institutional
    Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation
     
    Exhibit 10.19 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023
  
    10.12
     
    Exclusive
    License Agreement dated as of September 15, 2016, between National University of Singapore, Singapore Health Services Pte Ltd, the
    Registrant and 60P Australia Pty Ltd 
     
    Exhibit 10.20 to Registration Statement on Form S-1 (File No: 333-269483)
     
    January 31, 2023
  
    10.13